Related Experiment Video

Updated: Aug 20, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia

H A W Neil1, V Seagroatt, D J Betteridge

  • 1Division of Public Health & Primary Health Care, Institute of Health Sciences, University of Oxford, Old Road, Headington, Oxford OX3 7LF, UK. andrew.neil@wolfson.ox.ac.uk

Heart (British Cardiac Society)
|November 18, 2004
PubMed

Insights

Coronary artery disease (CAD) in treated familial hypercholesterolaemia is strongly linked to smoking. Emerging risk factors showed no association, highlighting the need for early smoking cessation interventions.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolaemia (FH) is an inherited condition leading to high low-density lipoprotein cholesterol levels.
  • Individuals with FH have a significantly increased risk of premature coronary artery disease (CAD).
  • Understanding factors influencing CAD susceptibility in treated FH is crucial for risk stratification.

Purpose of the Study:

  • To identify clinical and biochemical factors associated with variations in coronary artery disease (CAD) susceptibility among patients with treated heterozygous familial hypercholesterolaemia.
  • To investigate the role of emerging cardiovascular risk factors in the development of CAD in this specific patient population.

Main Methods:

  • A cross-sectional study involving 410 patients with treated heterozygous familial hypercholesterolaemia from six UK lipid clinics.
  • Data collection included clinical characteristics, biochemical markers, and documented presence of CAD.
  • Statistical analyses were performed to assess associations between various factors and CAD, adjusting for age, sex, and smoking status.

Main Results:

  • Coronary artery disease (CAD) was diagnosed in 49% of men and 28% of women.
  • Smoking was significantly associated with a higher prevalence of CAD (51% in smokers vs. 28% in non-smokers).
  • Lower high-density lipoprotein (HDL) cholesterol levels were significantly associated with CAD, particularly in women.

Conclusions:

  • Emerging coronary risk factors are not significantly associated with CAD in treated adults with familial hypercholesterolaemia.
  • A strong association between smoking and CAD underscores the importance of early identification and smoking prevention in childhood.
  • Targeted interventions focusing on smoking cessation are vital for managing CAD risk in familial hypercholesterolaemia patients.
Abstract

More Related Videos

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...